JP2003520223A5 - - Google Patents

Download PDF

Info

Publication number
JP2003520223A5
JP2003520223A5 JP2001552861A JP2001552861A JP2003520223A5 JP 2003520223 A5 JP2003520223 A5 JP 2003520223A5 JP 2001552861 A JP2001552861 A JP 2001552861A JP 2001552861 A JP2001552861 A JP 2001552861A JP 2003520223 A5 JP2003520223 A5 JP 2003520223A5
Authority
JP
Japan
Prior art keywords
composition
drug
dose
component
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001552861A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003520223A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/001925 external-priority patent/WO2001052813A1/en
Publication of JP2003520223A publication Critical patent/JP2003520223A/ja
Publication of JP2003520223A5 publication Critical patent/JP2003520223A5/ja
Withdrawn legal-status Critical Current

Links

JP2001552861A 2000-01-19 2001-01-19 薬物送達のためのマルチスパイク放出処方物 Withdrawn JP2003520223A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17685300P 2000-01-19 2000-01-19
US60/176,853 2000-01-19
PCT/US2001/001925 WO2001052813A1 (en) 2000-01-19 2001-01-19 Multi-spike release formulation for drug delivery

Publications (2)

Publication Number Publication Date
JP2003520223A JP2003520223A (ja) 2003-07-02
JP2003520223A5 true JP2003520223A5 (cg-RX-API-DMAC7.html) 2008-02-21

Family

ID=22646129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001552861A Withdrawn JP2003520223A (ja) 2000-01-19 2001-01-19 薬物送達のためのマルチスパイク放出処方物

Country Status (9)

Country Link
US (1) US6555127B2 (cg-RX-API-DMAC7.html)
EP (1) EP1248594B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003520223A (cg-RX-API-DMAC7.html)
AT (1) ATE312595T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001231018A1 (cg-RX-API-DMAC7.html)
DE (1) DE60115840T2 (cg-RX-API-DMAC7.html)
DK (1) DK1248594T3 (cg-RX-API-DMAC7.html)
ES (1) ES2258072T3 (cg-RX-API-DMAC7.html)
WO (1) WO2001052813A1 (cg-RX-API-DMAC7.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US20020187192A1 (en) * 2001-04-30 2002-12-12 Yatindra Joshi Pharmaceutical composition which reduces or eliminates drug abuse potential
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
CA2452874A1 (en) * 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
DE60223254T2 (de) 2001-07-06 2008-08-14 Penwest Pharmaceuticals Co. Verzögert freisetzende formulierungen von oxymorphon
US20030091635A1 (en) * 2001-09-26 2003-05-15 Baichwal Anand R. Opioid formulations having reduced potential for abuse
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
CA2395819A1 (en) * 2002-08-13 2004-02-13 Bernard Charles Sherman Dual-spike release formulation for oral drug delivery
US7988993B2 (en) 2002-12-09 2011-08-02 Andrx Pharmaceuticals, Inc. Oral controlled release dosage form
CA2529984C (en) * 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US8236349B2 (en) 2004-04-12 2012-08-07 Bend Research Inc. Taste-masked drugs in rupturing multiparticulates
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060024361A1 (en) * 2004-07-28 2006-02-02 Isa Odidi Disintegrant assisted controlled release technology
EP1786784B1 (en) 2004-08-20 2010-10-27 MannKind Corporation Catalysis of diketopiperazine synthesis
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
IN2014DN09128A (cg-RX-API-DMAC7.html) 2005-09-14 2015-07-10 Mannkind Corp
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN101389348A (zh) 2006-02-22 2009-03-18 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
KR101495146B1 (ko) 2006-03-16 2015-02-24 트리스 파마 인코포레이티드 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제
CA2648278C (en) * 2006-04-03 2019-05-28 Isa Odidi Drug delivery composition
JP5457830B2 (ja) 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2091519B1 (en) 2006-11-30 2015-06-24 Bend Research, Inc Multiparticulates of spray-coated drug and polymer on a meltable core
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US8202542B1 (en) 2007-05-31 2012-06-19 Tris Pharma Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
US20090124650A1 (en) * 2007-06-21 2009-05-14 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CN109568740B (zh) 2008-06-13 2022-05-27 曼金德公司 干粉吸入器和用于药物输送的系统
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
BR122020002400B1 (pt) 2008-06-20 2021-12-07 Mannkind Corporation Sistema de detecção de inalação de pó seco e sistema de monitoramento acoplável para um inalador de pó seco
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
WO2010053306A2 (ko) * 2008-11-07 2010-05-14 주식회사 삼양사 메칠페니데이트의 방출 제어용 약제학적 조성물
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
CA2764505C (en) 2009-06-12 2018-09-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
WO2011020032A2 (en) * 2009-08-13 2011-02-17 Kudco Ireland, Ltd. Pharmaceutical dosage form
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
US8287903B2 (en) 2011-02-15 2012-10-16 Tris Pharma Inc Orally effective methylphenidate extended release powder and aqueous suspension product
JP6133270B2 (ja) 2011-04-01 2017-05-24 マンカインド コーポレイション 薬剤カートリッジのためのブリスター包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
ES2717469T3 (es) 2012-08-15 2019-06-21 Tris Pharma Inc Comprimido masticable de metilfenidato de liberación prolongada
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
MX392016B (es) 2013-03-15 2025-03-21 Mannkind Corp Composiciones de dicetopiperazina microcristalina y métodos.
EP3021834A1 (en) 2013-07-18 2016-05-25 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002776A (en) * 1983-12-22 1991-03-26 Elan Corporation, Plc Controlled absorption diltiazem formulations
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US5885616A (en) * 1997-08-18 1999-03-23 Impax Pharmaceuticals, Inc. Sustained release drug delivery system suitable for oral administration
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
PL205109B1 (pl) 1998-11-02 2010-03-31 Elan Pharma Int Ltd Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
WO2000059481A1 (en) * 1999-04-06 2000-10-12 Pharmaquest Ltd. PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT

Similar Documents

Publication Publication Date Title
JP2003520223A5 (cg-RX-API-DMAC7.html)
US6555127B2 (en) Multi-spike release formulation for oral drug delivery
AU2001255509B2 (en) Taste masking coating composition
Gopalakrishnan et al. Floating drug delivery systems: a review
Ubhe et al. A brief overview on tablet and it’s types
EP1276470B1 (en) Taste masking coating composition
CA2879282C (en) Gastro-retentive drug delivery system
BRPI0213175B1 (pt) Oral galenical form macroparticulate for delayed and controlled release of a pharmaceutical active principles and use of microcapsules "reservoir"
EP1809251A2 (en) Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
US20150202158A1 (en) Gastro-retentive drug delivery system
CA3007577A1 (en) Compression-molded preparation
JP2004507487A (ja) 腸疾患治療薬
CN106822907B (zh) 一种含消旋卡多曲的双相释放制剂及其制备方法
WO2012006963A1 (zh) 在控释制剂中的聚合物增强剂
KR101680925B1 (ko) 불쾌미 마스킹 입자 및 이것을 함유하는 경구제제
JP2018500278A (ja) 外部粘膜に適用する剤形物品
WO1996021432A1 (en) Delivery of active substances by way of mucosal surfaces of pharyngeal and esophageal regions
JP2003306428A (ja) 服用性を改善した硬カプセル剤
US20180318228A1 (en) Method for a slow release of drugs from orally dissolving capsules
US7985427B2 (en) Gastric juice-resistant device for releasing mucoadhesive active substance excipients, and method for producing this gastric juice-resistant device
JP6812104B2 (ja) 経口固形組成物
EP1949900A2 (en) Controlled release solid formulation for oral administration as single dose sachet and method of preparation thereof
AU2016381918B2 (en) Compacted pharmaceutical preparation
TWI257312B (en) The composition and method of preparing acemetacin retard pellet and its dosage form
JP2008511585A (ja) 食事と共にするａｐｉ投与時に遅延効果を果たす経口投与調剤